Janssen gets FDA nod for type 2 diabetes drug

04/1/2013 | HealthDay News

The FDA has granted Janssen Pharmaceuticals approval for its type 2 diabetes drug Invokana. The drug, a sodium-glucose co-transporter 2 inhibitor, was the first of its class to gain federal approval.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ